160 related articles for article (PubMed ID: 10487478)
1. Myoclonic status epilepticus following high-dosage lamotrigine therapy.
Guerrini R; Belmonte A; Parmeggiani L; Perucca E
Brain Dev; 1999 Sep; 21(6):420-4. PubMed ID: 10487478
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
[TBL] [Abstract][Full Text] [Related]
3. Recurrent absence status epilepticus (spike-and-wave stupor) associated with lamotrigine therapy.
Hasan M; Lerman-Sagie T; Lev D; Watemberg N
J Child Neurol; 2006 Sep; 21(9):807-9. PubMed ID: 16970892
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine and seizure aggravation in severe myoclonic epilepsy.
Guerrini R; Dravet C; Genton P; Belmonte A; Kaminska A; Dulac O
Epilepsia; 1998 May; 39(5):508-12. PubMed ID: 9596203
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine in absence and primary generalized epilepsies.
Mikati MA; Holmes GL
J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity following addition of intravenous valproate to lamotrigine therapy.
Burneo JG; Limdi N; Kuzniecky RI; Knowlton RC; Mendez M; Lawn N; Faught E; Welty TE; Prasad A
Neurology; 2003 Jun; 60(12):1991-2. PubMed ID: 12821749
[TBL] [Abstract][Full Text] [Related]
8. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies.
Crespel A; Genton P; Berramdane M; Coubes P; Monicard C; Baldy-Moulinier M; Gelisse P
Neurology; 2005 Sep; 65(5):762-4. PubMed ID: 16157917
[TBL] [Abstract][Full Text] [Related]
10. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy.
Kluger G; Berz K; Holthausen H
Eur J Paediatr Neurol; 2001; 5(1):37-40. PubMed ID: 11277363
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine in typical absence epilepsy.
Buoni S; Grosso S; Fois A
Brain Dev; 1999 Jul; 21(5):303-6. PubMed ID: 10413016
[TBL] [Abstract][Full Text] [Related]
12. Non convulsive status epilepticus after replacement of valproate with lamotrigine.
Trinka E; Dilitz E; Unterberger I; Luef G; Deisenhammer F; Niedermüller U; Thaler C; Bauer G
J Neurol; 2002 Oct; 249(10):1417-22. PubMed ID: 12382160
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).
Donaldson JA; Glauser TA; Olberding LS
Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186
[TBL] [Abstract][Full Text] [Related]
14. [Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction].
Gélisse P; Crespel A
Rev Neurol (Paris); 2006 Nov; 162(11):1122-4. PubMed ID: 17086149
[TBL] [Abstract][Full Text] [Related]
15. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
Hosford DA; Wang Y
Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
[TBL] [Abstract][Full Text] [Related]
16. Disabling erratic myoclonus during lamotrigine therapy with high serum level--report of two cases.
Janszky J; Rásonyi G; Halász P; Olajos S; Perényi J; Szûcs A; Debreczeni T
Clin Neuropharmacol; 2000; 23(2):86-9. PubMed ID: 10803798
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of lamotrigine and vigabatrin in drug-resistant epilepsies of childhood.
Dimova PS; Korinthenberg R
Pediatr Neurol; 1999 Nov; 21(5):802-7. PubMed ID: 10593670
[TBL] [Abstract][Full Text] [Related]
18. Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes.
Dulac O; Kaminska A
J Child Neurol; 1997 Nov; 12 Suppl 1():S23-28. PubMed ID: 9429127
[TBL] [Abstract][Full Text] [Related]
19. Negative myoclonic status due to antiepileptic drug tapering: report of three cases.
Gambardella A; Aguglia U; Oliveri RL; Russo C; Zappia M; Quattrone A
Epilepsia; 1997 Jul; 38(7):819-23. PubMed ID: 9579909
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study.
Coppola G; Licciardi F; Sciscio N; Russo F; Carotenuto M; Pascotto A
Brain Dev; 2004 Jan; 26(1):26-9. PubMed ID: 14729411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
